Ferroptosis: Disease Associations and Therapeutic Target Exploration
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ferroptosis, a cell death process driven by iron, shows therapeutic promise for cancer and neurological disorders. Research focuses on its mechanisms and targeting GPX4 for disease treatment.
Area Of Science
- Biochemistry
- Cell Biology
- Pathology
Background
- Ferroptosis is a regulated cell death pathway implicated in diseases like cancer and neurodegeneration.
- It is characterized by iron accumulation and lipid peroxidation, presenting therapeutic opportunities.
- Understanding ferroptosis is crucial for developing targeted treatments for various pathologies.
Purpose Of The Study
- To summarize current knowledge on ferroptosis mechanisms.
- To review the association between ferroptosis and diseases.
- To explore potential therapeutic targets within ferroptosis pathways.
Main Methods
- Literature review of ferroptosis research.
- Analysis of signaling pathways involved in ferroptosis.
- Examination of ferroptosis's role in disease progression.
Main Results
- Ferroptosis is linked to cancer, neurodegenerative disorders, renal impairment, and metabolic diseases.
- Key regulators include iron, lipid peroxidation, and glutathione peroxidase-4 (GPX4).
- Specific pathways, like selenium's role in GPX4 activation, are being elucidated.
Conclusions
- Ferroptosis presents significant therapeutic potential for various diseases.
- Further research into molecular mechanisms and minimizing off-target effects is necessary.
- Targeting ferroptosis offers a promising strategy for novel disease treatments.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...